Chapter 1. Executive Summary
1.1. Market Snapshot
1.2. Global & Segmental Market Estimates & Forecasts,2022-2030 (USD Billion)
1.2.1. Global In-vivo Toxicology Market, by Region,2022-2030 (USD Billion)
1.2.2. Global In-vivo Toxicology Market, by Product & Services,2022-2030 (USD Billion)
1.2.3. Global In-vivo Toxicology Market, by Testing Type,2022-2030 (USD Billion)
1.2.4. Global In-vivo Toxicology Market, by Toxicity Endpoints,2022-2030 (USD Billion)
1.3. Key Trends
1.3.1 Economical effect of COVID-19 on the industry
1.4. Estimation Methodology
1.5. Research Assumption
Chapter 2. Global In-vivo Toxicology Market Definition and Scope
2.1. Objective of the Study
2.2. Market Definition & Scope
2.3. Scope of the Study
2.4. Years Considered for the Study
2.5. Currency Conversion Rates
Chapter 3. Global In-vivo Toxicology Market Overview
3.1 Global In-vivo Toxicology Market Dynamics
3.1.1 Impact Analysis,2022-2030
3.1.2 Drivers
3.1.2.1 Increasing pharmaceutical R&D activities
3.1.2.2 Rising demand for humanized animal models
3.1.2.3 Increasing pharmaceutical R&D activities
3.1.3 Restraints
3.1.4 Challenges
3.1.5 Opportunities
Chapter 4. Global In-vivo Toxicology Market Industry Analysis
4.1. Porters 5 Force Model
4.1.1. Bargaining Power of Buyers
4.1.2. Threat of Substitutes
4.1.3. Bargaining Power of Suppliers
4.1.4. Industry Rivalry
4.1.5. Threat of New Entrants
4.2. PEST Analysis
4.2.1. Political
4.2.2. Economical
4.2.3. Social
4.2.4. Technologica
4.3. Investment Adoption Model
4.4. Analyst Recommendation & Conclusion
Chapter 5. Global In-vivo Toxicology Market Breakdown By Segmentations
5.1 Global In-vivo Toxicology Market By Product & Services
5.1.1. Market Snapshot
5.1.2. Global In-vivo Toxicology Market by Product & Services, Performance - Potential Analysis
5.1.3. Global In-vivo Toxicology Market Estimates & Forecasts by Product & Services 2017-2030 (USD Billion)
5.1.4. In-vivo Toxicology Market, Sub Segment Analysis
5.1.4.1. Consumables
5.1.4.1.1 Regional breakdown estimates & forecasts, 2017 - 2030
5.1.4.2. Reagents and Kits
5.1.4.2.1 Regional breakdown estimates & forecasts, 2017 - 2030
5.1.4.3. Animal Models
5.1.4.3.1 Regional breakdown estimates & forecasts, 2017 - 2030
5.1.4.4. Instruments
5.1.4.4.1 Regional breakdown estimates & forecasts, 2017 - 2030
5.2 Global In-vivo Toxicology Market By Testing Type
5.2.1 Market Snapshot
5.2.2. Global In-vivo Toxicology Market by Testing Type, Performance - Potential Analysis
5.2.3. Global In-vivo Toxicology Market Estimates & Forecasts by Testing Type 2017-2030 (USD Billion)
5.2.4. In-vivo Toxicology Market, Sub Segment Analysis
5.2.4.1. Chronic Toxicity Testing
5.2.4.1.1 Regional breakdown estimates & forecasts, 2017 - 2030
5.2.4.2. Sub-chronic Toxicity Testing
5.2.4.2.1 Regional breakdown estimates & forecasts, 2017 - 2030
5.2.4.3. Sub-acute Toxicity Testing
5.2.4.3.1 Regional breakdown estimates & forecasts, 2017 - 2030
5.2.4.4. Acute Toxicity Testing
5.2.4.4.1 Regional breakdown estimates & forecasts, 2017 - 2030
5.3 Global In-vivo Toxicology Market By Toxicity Endpoints
5.3.1 Market Snapshot
5.3.2 Global In-vivo Toxicology Market by Toxicity Endpoints, Performance - Potential Analysis
5.3.3 Global In-vivo Toxicology Market Estimates & Forecasts by Toxicity Endpoints 2017-2030 (USD Billion)
5.3.4 In-vivo Toxicology Market, Sub Segment Analysis
5.3.4.1. Immunotoxicity
5.3.4.1.1 Regional breakdown estimates & forecasts, 2017 - 2030
5.3.4.2. Systemic Toxicity
5.3.4.2.1 Regional breakdown estimates & forecasts, 2017 - 2030
5.3.4.3. Carcinogenicity
5.3.4.3.1 Regional breakdown estimates & forecasts, 2017 - 2030
5.3.4.4. Genotoxicity
5.3.4.4.1 Regional breakdown estimates & forecasts, 2017 - 2030
5.3.4.5. Developmental and Reproductive Toxicity
5.3.4.5.1 Regional breakdown estimates & forecasts, 2017 - 2030
5.3.4.6. Other Toxicity Endpoints
5.3.4.6.1 Regional breakdown estimates & forecasts, 2017 - 2030
Chapter6. Global In-vivo Toxicology Market, Regional Analysis
6.1. In-vivo Toxicology Market, Regional Market Snapshot
6.2. North America In-vivo Toxicology Market
6.2.1. US In-vivo Toxicology Market
6.2.1.1. COVID-19 impact Analysis
6.2.2. Canada In-vivo Toxicology Market
6.2.2.1. COVID-19 impact Analysis
6.2.3. Mexico In-vivo Toxicology Market
6.2.3.1. COVID-19 impact Analysis
6.3. Europe In-vivo Toxicology Market Snapshot
6.3.1. U.K. In-vivo Toxicology Market
6.3.1.1. COVID-19 impact Analysis
6.3.2. Germany In-vivo Toxicology Market
6.3.2.1. COVID-19 impact Analysis
6.3.3. France In-vivo Toxicology Market
6.3.3.1. COVID-19 impact Analysis
6.3.4. Spain In-vivo Toxicology Market
6.3.4.1. COVID-19 impact Analysis
6.3.5. Italy In-vivo Toxicology Market
6.3.5.1. COVID-19 impact Analysis
6.3.6. Italy In-vivo Toxicology Market
6.3.6.1. COVID-19 impact Analysis
6.3.7. ROE In-vivo Toxicology Market
6.3.7.1. COVID-19 impact Analysis
6.4. Asia Pacific In-vivo Toxicology Market Snapshot
6.4.1. China In-vivo Toxicology Market
6.4.1.1. COVID-19 impact Analysis
6.4.2. India In-vivo Toxicology Market
6.4.2.1. COVID-19 impact Analysis
6.4.3. Japan In-vivo Toxicology Market
6.4.3.1. COVID-19 impact Analysis
6.4.4. Australia In-vivo Toxicology Market
6.4.4.1. COVID-19 impact Analysis
6.4.5. South Korea In-vivo Toxicology Market
6.4.5.1. COVID-19 impact Analysis
6.4.6. Rest of Asia In-vivo Toxicology Market
6.4.6.1. COVID-19 impact Analysis
6.5. South America In-vivo Toxicology Market Snapshot
6.5.1. Brazil In-vivo Toxicology Market
6.5.1.1. COVID-19 impact Analysis
6.5.2. Argentina In-vivo Toxicology Market
6.5.2.1. COVID-19 impact Analysis
6.5.3. Rest of South America In-vivo Toxicology Market
6.5.3.1. COVID-19 impact Analysis
6.6. Middle East & Africa In-vivo Toxicology Market Snapshot
6.6.1. UAE In-vivo Toxicology Market
6.6.1.1. COVID-19 impact Analysis
6.6.2. Saudi Arabia In-vivo Toxicology Market
6.6.2.1. COVID-19 impact Analysis
6.6.3. South Africa In-vivo Toxicology Market
6.6.3.1. COVID-19 impact Analysis
6.6.4. Rest of MEA In-vivo Toxicology Market
6.6.4.1. COVID-19 impact Analysis
Chapter 7. Competitive Intelligence
7.1. Company Profiles
7.1.1 Danaher
7.1.1.1. Key Information
7.1.1.2. Overview
7.1.1.3. Financial (Subject to Data Availability)
7.1.1.4. Product Summary
7.1.1.5. Recent Developments
7.1.2 Thermo Fisher Scientific
7.1.3 Charles River
7.1.4 Covance
7.1.5 The Jackson Laboratory
7.1.6 Taconic Biosciences Inc
7.1.7 Eurofins Scientific
7.1.8 Envigoand Dynamic Systems Inc
Chapter 8. Research Process
8.1. Research Process
8.1.1. Data Mining
8.1.2. Analysis
8.1.3. Market Estimation
8.1.4. Validation
8.1.5. Publishing
8.2. Research Attributes
8.3. Research Assumption